Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228583 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
The majority of our patients deemed unfavorable had an excellent outcome despite undergoing a significantly abbreviated regimen. Application of factors used by the GHSG defined a less favorable subset for FFP but with no impact on OS. As therapy for early-stage disease moves to further reductions in therapy, these factors take on added importance in the interpretation of current trial results and design of future studies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ranjana H. M.D., Richard T. M.D., Lauren S. M.D., David M. M.D., Joseph M.D., Saul A. M.D., Sandra J. M.D.,